T-cell Immunology of COVID-19 infection and vaccination

Acces sibility Controls

Implementing Organization

National Institute of Immunology (NII)

Principal Investigator

Dr Nimesh Gupta

Scientist

National Institute of Immunology (NII)

About

This study aims to address crucial questions on the (i) quality and durability of T-cell immunity after infection and vaccination, (ii) vaccination outcome in virus infected individuals versus naïve population, and (iii) whether the immunity acquired after recovery from infection or vaccination will protect against the prevalent virus variants of concerns (VOCs). The major focus is to characterise the SARS-CoV-2 specific T-cell and antibody responses in a longitudinal infection or vaccination cohort.

Patents

Achievements

Outcome / Output

The outcome of this work will provide (i) the crucial insight into the human T-cells responses to SARS-CoV-2 and COVID-19 vaccines, (ii) quality and durability of protective immunity after vaccination, (iii) vaccination outcome in virus infected individuals versus naïve population, and (iv) efficacy of vaccines against recently circulating or future variants of concerns (VOCs).

Publications

Related Research

View All

Funding Organization

Department of Science and Technology (DST)

Department of Biotechnology (DBT)

Quick Information

Focus Area

COVID-19 infection and vaccination

Start Year

2020

Sanction Amount

₹ NA

Status

Ongoing

Contact

nimesh.gupta@nii.ac.in

Output

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

No. of Patents

Filed : 00

Grant : 00

Acces sibility Controls

Research Projects